I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is proud to announce a new shipping facility located in Calgary, Alberta

Montreal, February 3, 2022 (Globe Newswire) With the recent launch of its line of dry eye diagnostics, management, and treatment solutions into the United States,

January 24, 2022 I-MED Pharma continues to grow and expand! We are pleased to announce that our corporate office is moving to the new location

Montreal, December 15, 2021 (GLOBE NEWSWIRE) NTC Srl, R&D driven pharmaceutical company with headquarters in Italy, and I-MED Pharma Inc., a Canadian company specializing in

MONTREAL, December 9, 2021 (GLOBE NEWSWIRE) I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is proud to announce the expansion

Montreal, November 9, 2021 (Globe Newswire) With the recent expansion into the United States, I-MED Pharma USA is proud to announce the appointment of Michelle

Montreal, November 8, 2021 (Globe Newswire) With the recent expansion into the United States, I-MED Pharma USA is proud to announce the appointment of Brent

October 7, 2021 (Montreal, QC, Canada) Article published in September issue of MEDTECH OUTLOOK Magazine medicaltechoutlook.com Ocular surface disorders (OSDs) typically indicate damage to the

Montreal, QC, Canada Article published in Optical Prism October issue ANNE MARIE QUENNEVILLE – VP OF SALES & BRAND MANAGEMENT FEATURED IN OPTICAL PRISM MAGAZINE